Abstract
Abstract
Objective
To explore the ability of artificial intelligence (AI) to classify breast cancer by mammographic density in an organized screening program.
Materials and method
We included information about 99,489 examinations from 74,941 women who participated in BreastScreen Norway, 2013–2019. All examinations were analyzed with an AI system that assigned a malignancy risk score (AI score) from 1 (lowest) to 10 (highest) for each examination. Mammographic density was classified into Volpara density grade (VDG), VDG1–4; VDG1 indicated fatty and VDG4 extremely dense breasts. Screen-detected and interval cancers with an AI score of 1–10 were stratified by VDG.
Results
We found 10,406 (10.5% of the total) examinations to have an AI risk score of 10, of which 6.7% (704/10,406) was breast cancer. The cancers represented 89.7% (617/688) of the screen-detected and 44.6% (87/195) of the interval cancers. 20.3% (20,178/99,489) of the examinations were classified as VDG1 and 6.1% (6047/99,489) as VDG4. For screen-detected cancers, 84.0% (68/81, 95% CI, 74.1–91.2) had an AI score of 10 for VDG1, 88.9% (328/369, 95% CI, 85.2–91.9) for VDG2, 92.5% (185/200, 95% CI, 87.9–95.7) for VDG3, and 94.7% (36/38, 95% CI, 82.3–99.4) for VDG4. For interval cancers, the percentages with an AI score of 10 were 33.3% (3/9, 95% CI, 7.5–70.1) for VDG1 and 48.0% (12/25, 95% CI, 27.8–68.7) for VDG4.
Conclusion
The tested AI system performed well according to cancer detection across all density categories, especially for extremely dense breasts. The highest proportion of screen-detected cancers with an AI score of 10 was observed for women classified as VDG4.
Clinical relevance statement
Our study demonstrates that AI can correctly classify the majority of screen-detected and about half of the interval breast cancers, regardless of breast density.
Key Points
• Mammographic density is important to consider in the evaluation of artificial intelligence in mammographic screening.
• Given a threshold representing about 10% of those with the highest malignancy risk score by an AI system, we found an increasing percentage of cancers with increasing mammographic density.
• Artificial intelligence risk score and mammographic density combined may help triage examinations to reduce workload for radiologists.
Funder
Kreftforeningen
Norwegian Institute of Public Health
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Lauby-Secretan B, Scoccianti C, Loomis D et al (2015) Breast-cancer screening–viewpoint of the IARC Working Group. N Engl J Med 372(24):2353–2358
2. European Commission initiative on breast cancer (2021) Manual for Breast Cancer Services. European Quality Assurance Scheme for Breast Cancer Services. Cited February 2024: https://cancer-screening-and-care.jrc.ec.europa.eu/en/ecibc/breast-quality-assurance-scheme
3. Bjørnson EW, Holen ÅS, Sagstad S et al (2022) BreastScreen Norway: 25 years of organized screening. Oslo: Cancer Registry of Norway. Cited February, 2024. Avaliable from: https://www.kreftregisteret.no/Generelt/Rapporter/Mammografiprogrammet/25-arsrapport-mammografiprogrammet/
4. Sardanelli F, Aase HS, Álvarez M et al (2017) Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden Switzerland and Turkey. Eur Radiol 27(7):2737–2743
5. Harkness EF, Astley SM, Evans DG (2020) Risk-based breast cancer screening strategies in women. Best Pract Res Clin Obstet Gynaecol 65:3–17
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献